Global Genetic Screening for Carrier Diseases Market Growth (Status and Outlook) 2026-2032
The global Genetic Screening for Carrier Diseases market size is predicted to grow from US$ 2557 million in 2025 to US$ 4799 million in 2032; it is expected to grow at a CAGR of 9.6% from 2026 to 2032.
Genetic Screening for Carrier Diseases refers to detecting whether an individual carries the causative gene of a certain genetic disease. In human genetics, some diseases are caused by recessively inherited gene mutations. These mutations usually do not cause the disease in the individual themselves, but if two carriers have offspring, they may increase the risk of the offspring suffering from the genetic disease. Genetic screening for genetic disease carriers can help individuals, especially couples planning to have children, by helping to assess the risk of their future offspring developing specific genetic diseases. If both partners are carriers, they are more likely to have offspring with the disease. Through this screening, couples can better understand their genetic status, make more informed reproductive decisions, and seek genetic counseling and medical intervention when needed.
The genetic screening for carrier diseases market is transitioning from a niche, risk-based offering into a more standardized element of reproductive care as clinical practice moves toward earlier identification of inherited risk and simpler pan-ethnic approaches. Growth is supported by declining sequencing costs, expanding awareness among patients and clinicians, and the operational convenience of comprehensive panels that reduce reliance on ancestry assumptions. Competitive differentiation increasingly depends on the quality and consistency of variant interpretation, the clarity of reporting for non-specialist providers, turnaround time, and the ability to embed testing into fertility, obstetrics, and primary care workflows with counseling support and digital ordering. At the same time, the market faces reimbursement and pricing pressure, which favors scaled laboratory operations, efficient logistics, and evidence generation that links screening to measurable clinical utility and downstream cost avoidance.
LPI (LP Information)' newest research report, the ?Genetic Screening for Carrier Diseases Industry Forecast? looks at past sales and reviews total world Genetic Screening for Carrier Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected Genetic Screening for Carrier Diseases sales for 2026 through 2032. With Genetic Screening for Carrier Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Screening for Carrier Diseases industry.
This Insight Report provides a comprehensive analysis of the global Genetic Screening for Carrier Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genetic Screening for Carrier Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Genetic Screening for Carrier Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Screening for Carrier Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Screening for Carrier Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Screening for Carrier Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
Genetic Screening for Carrier Diseases refers to detecting whether an individual carries the causative gene of a certain genetic disease. In human genetics, some diseases are caused by recessively inherited gene mutations. These mutations usually do not cause the disease in the individual themselves, but if two carriers have offspring, they may increase the risk of the offspring suffering from the genetic disease. Genetic screening for genetic disease carriers can help individuals, especially couples planning to have children, by helping to assess the risk of their future offspring developing specific genetic diseases. If both partners are carriers, they are more likely to have offspring with the disease. Through this screening, couples can better understand their genetic status, make more informed reproductive decisions, and seek genetic counseling and medical intervention when needed.
The genetic screening for carrier diseases market is transitioning from a niche, risk-based offering into a more standardized element of reproductive care as clinical practice moves toward earlier identification of inherited risk and simpler pan-ethnic approaches. Growth is supported by declining sequencing costs, expanding awareness among patients and clinicians, and the operational convenience of comprehensive panels that reduce reliance on ancestry assumptions. Competitive differentiation increasingly depends on the quality and consistency of variant interpretation, the clarity of reporting for non-specialist providers, turnaround time, and the ability to embed testing into fertility, obstetrics, and primary care workflows with counseling support and digital ordering. At the same time, the market faces reimbursement and pricing pressure, which favors scaled laboratory operations, efficient logistics, and evidence generation that links screening to measurable clinical utility and downstream cost avoidance.
LPI (LP Information)' newest research report, the ?Genetic Screening for Carrier Diseases Industry Forecast? looks at past sales and reviews total world Genetic Screening for Carrier Diseases sales in 2025, providing a comprehensive analysis by region and market sector of projected Genetic Screening for Carrier Diseases sales for 2026 through 2032. With Genetic Screening for Carrier Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Screening for Carrier Diseases industry.
This Insight Report provides a comprehensive analysis of the global Genetic Screening for Carrier Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genetic Screening for Carrier Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Genetic Screening for Carrier Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Screening for Carrier Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Screening for Carrier Diseases.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Screening for Carrier Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
- NGS
- Whole Exome Sequencing
- Others
- Preconception Screening
- Prenatal Screening
- Single-condition Screening
- Targeted multi-condition Screening
- Couple
- Individual
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- Eurofins Scientific
- Illumina
- Labcorp
- Quest Diagnostics
- MedGenome
- Myriad Genetics
- Natera
- OPKO Health
- 23andMe
- Mayo Clinic Laboratories
- Baylor Genetics
- GeneDx
- Fulgent Genetics
- NxGen MDx
- Sonic Genetics
- Ambry Genetics
- PreventionGenetics
- DiaSorin
- SYNLAB
- BGI Genomics
- Berry Genomics
- Annaroad
- Jiajian Medical Testing
- Genesky
- Weihansi Biomedical Technology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetic Screening for Carrier Diseases Market Size (2021-2032)
2.1.2 Genetic Screening for Carrier Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Genetic Screening for Carrier Diseases by Country/Region (2021, 2025 & 2032)
2.2 Genetic Screening for Carrier Diseases Segment by Type
2.2.1 NGS
2.2.2 Whole Exome Sequencing
2.2.3 Others
2.2.4 Genetic Screening for Carrier Diseases Market Size by Type
2.2.4.1 Genetic Screening for Carrier Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
2.3 Genetic Screening for Carrier Diseases Segment by Application
2.3.1 Couple
2.3.2 Individual
2.3.3 Genetic Screening for Carrier Diseases Market Size by Application
2.3.3.1 Genetic Screening for Carrier Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
3 GENETIC SCREENING FOR CARRIER DISEASES MARKET SIZE BY PLAYER
3.1 Genetic Screening for Carrier Diseases Market Size Market Share by Player
3.1.1 Global Genetic Screening for Carrier Diseases Revenue by Player (2021-2026)
3.1.2 Global Genetic Screening for Carrier Diseases Revenue Market Share by Player (2021-2026)
3.2 Global Genetic Screening for Carrier Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENETIC SCREENING FOR CARRIER DISEASES BY REGION
4.1 Genetic Screening for Carrier Diseases Market Size by Region (2021-2026)
4.2 Global Genetic Screening for Carrier Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genetic Screening for Carrier Diseases Market Size Growth (2021-2026)
4.4 APAC Genetic Screening for Carrier Diseases Market Size Growth (2021-2026)
4.5 Europe Genetic Screening for Carrier Diseases Market Size Growth (2021-2026)
4.6 Middle East & Africa Genetic Screening for Carrier Diseases Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
5.2 Americas Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
5.3 Americas Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetic Screening for Carrier Diseases Market Size by Region (2021-2026)
6.2 APAC Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
6.3 APAC Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
7.2 Europe Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
7.3 Europe Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetic Screening for Carrier Diseases by Region (2021-2026)
8.2 Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
8.3 Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENETIC SCREENING FOR CARRIER DISEASES MARKET FORECAST
10.1 Global Genetic Screening for Carrier Diseases Forecast by Region (2027-2032)
10.1.1 Global Genetic Screening for Carrier Diseases Forecast by Region (2027-2032)
10.1.2 Americas Genetic Screening for Carrier Diseases Forecast
10.1.3 APAC Genetic Screening for Carrier Diseases Forecast
10.1.4 Europe Genetic Screening for Carrier Diseases Forecast
10.1.5 Middle East & Africa Genetic Screening for Carrier Diseases Forecast
10.2 Americas Genetic Screening for Carrier Diseases Forecast by Country (2027-2032)
10.2.1 United States Market Genetic Screening for Carrier Diseases Forecast
10.2.2 Canada Market Genetic Screening for Carrier Diseases Forecast
10.2.3 Mexico Market Genetic Screening for Carrier Diseases Forecast
10.2.4 Brazil Market Genetic Screening for Carrier Diseases Forecast
10.3 APAC Genetic Screening for Carrier Diseases Forecast by Region (2027-2032)
10.3.1 China Genetic Screening for Carrier Diseases Market Forecast
10.3.2 Japan Market Genetic Screening for Carrier Diseases Forecast
10.3.3 Korea Market Genetic Screening for Carrier Diseases Forecast
10.3.4 Southeast Asia Market Genetic Screening for Carrier Diseases Forecast
10.3.5 India Market Genetic Screening for Carrier Diseases Forecast
10.3.6 Australia Market Genetic Screening for Carrier Diseases Forecast
10.4 Europe Genetic Screening for Carrier Diseases Forecast by Country (2027-2032)
10.4.1 Germany Market Genetic Screening for Carrier Diseases Forecast
10.4.2 France Market Genetic Screening for Carrier Diseases Forecast
10.4.3 UK Market Genetic Screening for Carrier Diseases Forecast
10.4.4 Italy Market Genetic Screening for Carrier Diseases Forecast
10.4.5 Russia Market Genetic Screening for Carrier Diseases Forecast
10.5 Middle East & Africa Genetic Screening for Carrier Diseases Forecast by Region (2027-2032)
10.5.1 Egypt Market Genetic Screening for Carrier Diseases Forecast
10.5.2 South Africa Market Genetic Screening for Carrier Diseases Forecast
10.5.3 Israel Market Genetic Screening for Carrier Diseases Forecast
10.5.4 Turkey Market Genetic Screening for Carrier Diseases Forecast
10.6 Global Genetic Screening for Carrier Diseases Forecast by Type (2027-2032)
10.7 Global Genetic Screening for Carrier Diseases Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Genetic Screening for Carrier Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product Offered
11.1.3 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Information
11.2.2 Eurofins Scientific Genetic Screening for Carrier Diseases Product Offered
11.2.3 Eurofins Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Eurofins Scientific Main Business Overview
11.2.5 Eurofins Scientific Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Genetic Screening for Carrier Diseases Product Offered
11.3.3 Illumina Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Invitae
11.4.1 Invitae Company Information
11.4.2 Invitae Genetic Screening for Carrier Diseases Product Offered
11.4.3 Invitae Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Invitae Main Business Overview
11.4.5 Invitae Latest Developments
11.5 MedGenome
11.5.1 MedGenome Company Information
11.5.2 MedGenome Genetic Screening for Carrier Diseases Product Offered
11.5.3 MedGenome Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 MedGenome Main Business Overview
11.5.5 MedGenome Latest Developments
11.6 Myriad Genetics
11.6.1 Myriad Genetics Company Information
11.6.2 Myriad Genetics Genetic Screening for Carrier Diseases Product Offered
11.6.3 Myriad Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Myriad Genetics Main Business Overview
11.6.5 Myriad Genetics Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Genetic Screening for Carrier Diseases Product Offered
11.7.3 Roche Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Natera
11.8.1 Natera Company Information
11.8.2 Natera Genetic Screening for Carrier Diseases Product Offered
11.8.3 Natera Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Natera Main Business Overview
11.8.5 Natera Latest Developments
11.9 OPKO Health
11.9.1 OPKO Health Company Information
11.9.2 OPKO Health Genetic Screening for Carrier Diseases Product Offered
11.9.3 OPKO Health Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 OPKO Health Main Business Overview
11.9.5 OPKO Health Latest Developments
11.10 23andMe
11.10.1 23andMe Company Information
11.10.2 23andMe Genetic Screening for Carrier Diseases Product Offered
11.10.3 23andMe Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 23andMe Main Business Overview
11.10.5 23andMe Latest Developments
11.11 bioMerieux
11.11.1 bioMerieux Company Information
11.11.2 bioMerieux Genetic Screening for Carrier Diseases Product Offered
11.11.3 bioMerieux Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 bioMerieux Main Business Overview
11.11.5 bioMerieux Latest Developments
11.12 EKF Diagnostics
11.12.1 EKF Diagnostics Company Information
11.12.2 EKF Diagnostics Genetic Screening for Carrier Diseases Product Offered
11.12.3 EKF Diagnostics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 EKF Diagnostics Main Business Overview
11.12.5 EKF Diagnostics Latest Developments
11.13 Gene by Gene (myDNA)
11.13.1 Gene by Gene (myDNA) Company Information
11.13.2 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product Offered
11.13.3 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Gene by Gene (myDNA) Main Business Overview
11.13.5 Gene by Gene (myDNA) Latest Developments
11.14 Fulgent Genetics
11.14.1 Fulgent Genetics Company Information
11.14.2 Fulgent Genetics Genetic Screening for Carrier Diseases Product Offered
11.14.3 Fulgent Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Fulgent Genetics Main Business Overview
11.14.5 Fulgent Genetics Latest Developments
11.15 NxGen MDx
11.15.1 NxGen MDx Company Information
11.15.2 NxGen MDx Genetic Screening for Carrier Diseases Product Offered
11.15.3 NxGen MDx Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 NxGen MDx Main Business Overview
11.15.5 NxGen MDx Latest Developments
11.16 Sonic Genetics
11.16.1 Sonic Genetics Company Information
11.16.2 Sonic Genetics Genetic Screening for Carrier Diseases Product Offered
11.16.3 Sonic Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Sonic Genetics Main Business Overview
11.16.5 Sonic Genetics Latest Developments
11.17 My Baby
11.17.1 My Baby Company Information
11.17.2 My Baby Genetic Screening for Carrier Diseases Product Offered
11.17.3 My Baby Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 My Baby Main Business Overview
11.17.5 My Baby Latest Developments
11.18 AncestryDNA
11.18.1 AncestryDNA Company Information
11.18.2 AncestryDNA Genetic Screening for Carrier Diseases Product Offered
11.18.3 AncestryDNA Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 AncestryDNA Main Business Overview
11.18.5 AncestryDNA Latest Developments
11.19 DiaSorin
11.19.1 DiaSorin Company Information
11.19.2 DiaSorin Genetic Screening for Carrier Diseases Product Offered
11.19.3 DiaSorin Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 DiaSorin Main Business Overview
11.19.5 DiaSorin Latest Developments
11.20 Grifols
11.20.1 Grifols Company Information
11.20.2 Grifols Genetic Screening for Carrier Diseases Product Offered
11.20.3 Grifols Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Grifols Main Business Overview
11.20.5 Grifols Latest Developments
11.21 BGI Genomics
11.21.1 BGI Genomics Company Information
11.21.2 BGI Genomics Genetic Screening for Carrier Diseases Product Offered
11.21.3 BGI Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 BGI Genomics Main Business Overview
11.21.5 BGI Genomics Latest Developments
11.22 Chigene
11.22.1 Chigene Company Information
11.22.2 Chigene Genetic Screening for Carrier Diseases Product Offered
11.22.3 Chigene Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Chigene Main Business Overview
11.22.5 Chigene Latest Developments
11.23 Jiajian Medical Testing
11.23.1 Jiajian Medical Testing Company Information
11.23.2 Jiajian Medical Testing Genetic Screening for Carrier Diseases Product Offered
11.23.3 Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Jiajian Medical Testing Main Business Overview
11.23.5 Jiajian Medical Testing Latest Developments
11.24 Genesky
11.24.1 Genesky Company Information
11.24.2 Genesky Genetic Screening for Carrier Diseases Product Offered
11.24.3 Genesky Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Genesky Main Business Overview
11.24.5 Genesky Latest Developments
11.25 Berry Genomics
11.25.1 Berry Genomics Company Information
11.25.2 Berry Genomics Genetic Screening for Carrier Diseases Product Offered
11.25.3 Berry Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Berry Genomics Main Business Overview
11.25.5 Berry Genomics Latest Developments
11.26 Weihansi Biomedical Technology
11.26.1 Weihansi Biomedical Technology Company Information
11.26.2 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product Offered
11.26.3 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Weihansi Biomedical Technology Main Business Overview
11.26.5 Weihansi Biomedical Technology Latest Developments
11.27 Annaroad
11.27.1 Annaroad Company Information
11.27.2 Annaroad Genetic Screening for Carrier Diseases Product Offered
11.27.3 Annaroad Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Annaroad Main Business Overview
11.27.5 Annaroad Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetic Screening for Carrier Diseases Market Size (2021-2032)
2.1.2 Genetic Screening for Carrier Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Genetic Screening for Carrier Diseases by Country/Region (2021, 2025 & 2032)
2.2 Genetic Screening for Carrier Diseases Segment by Type
2.2.1 NGS
2.2.2 Whole Exome Sequencing
2.2.3 Others
2.2.4 Genetic Screening for Carrier Diseases Market Size by Type
2.2.4.1 Genetic Screening for Carrier Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
2.3 Genetic Screening for Carrier Diseases Segment by Application
2.3.1 Couple
2.3.2 Individual
2.3.3 Genetic Screening for Carrier Diseases Market Size by Application
2.3.3.1 Genetic Screening for Carrier Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
3 GENETIC SCREENING FOR CARRIER DISEASES MARKET SIZE BY PLAYER
3.1 Genetic Screening for Carrier Diseases Market Size Market Share by Player
3.1.1 Global Genetic Screening for Carrier Diseases Revenue by Player (2021-2026)
3.1.2 Global Genetic Screening for Carrier Diseases Revenue Market Share by Player (2021-2026)
3.2 Global Genetic Screening for Carrier Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENETIC SCREENING FOR CARRIER DISEASES BY REGION
4.1 Genetic Screening for Carrier Diseases Market Size by Region (2021-2026)
4.2 Global Genetic Screening for Carrier Diseases Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genetic Screening for Carrier Diseases Market Size Growth (2021-2026)
4.4 APAC Genetic Screening for Carrier Diseases Market Size Growth (2021-2026)
4.5 Europe Genetic Screening for Carrier Diseases Market Size Growth (2021-2026)
4.6 Middle East & Africa Genetic Screening for Carrier Diseases Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
5.2 Americas Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
5.3 Americas Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetic Screening for Carrier Diseases Market Size by Region (2021-2026)
6.2 APAC Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
6.3 APAC Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
7.2 Europe Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
7.3 Europe Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetic Screening for Carrier Diseases by Region (2021-2026)
8.2 Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
8.3 Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENETIC SCREENING FOR CARRIER DISEASES MARKET FORECAST
10.1 Global Genetic Screening for Carrier Diseases Forecast by Region (2027-2032)
10.1.1 Global Genetic Screening for Carrier Diseases Forecast by Region (2027-2032)
10.1.2 Americas Genetic Screening for Carrier Diseases Forecast
10.1.3 APAC Genetic Screening for Carrier Diseases Forecast
10.1.4 Europe Genetic Screening for Carrier Diseases Forecast
10.1.5 Middle East & Africa Genetic Screening for Carrier Diseases Forecast
10.2 Americas Genetic Screening for Carrier Diseases Forecast by Country (2027-2032)
10.2.1 United States Market Genetic Screening for Carrier Diseases Forecast
10.2.2 Canada Market Genetic Screening for Carrier Diseases Forecast
10.2.3 Mexico Market Genetic Screening for Carrier Diseases Forecast
10.2.4 Brazil Market Genetic Screening for Carrier Diseases Forecast
10.3 APAC Genetic Screening for Carrier Diseases Forecast by Region (2027-2032)
10.3.1 China Genetic Screening for Carrier Diseases Market Forecast
10.3.2 Japan Market Genetic Screening for Carrier Diseases Forecast
10.3.3 Korea Market Genetic Screening for Carrier Diseases Forecast
10.3.4 Southeast Asia Market Genetic Screening for Carrier Diseases Forecast
10.3.5 India Market Genetic Screening for Carrier Diseases Forecast
10.3.6 Australia Market Genetic Screening for Carrier Diseases Forecast
10.4 Europe Genetic Screening for Carrier Diseases Forecast by Country (2027-2032)
10.4.1 Germany Market Genetic Screening for Carrier Diseases Forecast
10.4.2 France Market Genetic Screening for Carrier Diseases Forecast
10.4.3 UK Market Genetic Screening for Carrier Diseases Forecast
10.4.4 Italy Market Genetic Screening for Carrier Diseases Forecast
10.4.5 Russia Market Genetic Screening for Carrier Diseases Forecast
10.5 Middle East & Africa Genetic Screening for Carrier Diseases Forecast by Region (2027-2032)
10.5.1 Egypt Market Genetic Screening for Carrier Diseases Forecast
10.5.2 South Africa Market Genetic Screening for Carrier Diseases Forecast
10.5.3 Israel Market Genetic Screening for Carrier Diseases Forecast
10.5.4 Turkey Market Genetic Screening for Carrier Diseases Forecast
10.6 Global Genetic Screening for Carrier Diseases Forecast by Type (2027-2032)
10.7 Global Genetic Screening for Carrier Diseases Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Genetic Screening for Carrier Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product Offered
11.1.3 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Information
11.2.2 Eurofins Scientific Genetic Screening for Carrier Diseases Product Offered
11.2.3 Eurofins Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Eurofins Scientific Main Business Overview
11.2.5 Eurofins Scientific Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Genetic Screening for Carrier Diseases Product Offered
11.3.3 Illumina Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Invitae
11.4.1 Invitae Company Information
11.4.2 Invitae Genetic Screening for Carrier Diseases Product Offered
11.4.3 Invitae Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Invitae Main Business Overview
11.4.5 Invitae Latest Developments
11.5 MedGenome
11.5.1 MedGenome Company Information
11.5.2 MedGenome Genetic Screening for Carrier Diseases Product Offered
11.5.3 MedGenome Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 MedGenome Main Business Overview
11.5.5 MedGenome Latest Developments
11.6 Myriad Genetics
11.6.1 Myriad Genetics Company Information
11.6.2 Myriad Genetics Genetic Screening for Carrier Diseases Product Offered
11.6.3 Myriad Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Myriad Genetics Main Business Overview
11.6.5 Myriad Genetics Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Genetic Screening for Carrier Diseases Product Offered
11.7.3 Roche Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Natera
11.8.1 Natera Company Information
11.8.2 Natera Genetic Screening for Carrier Diseases Product Offered
11.8.3 Natera Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Natera Main Business Overview
11.8.5 Natera Latest Developments
11.9 OPKO Health
11.9.1 OPKO Health Company Information
11.9.2 OPKO Health Genetic Screening for Carrier Diseases Product Offered
11.9.3 OPKO Health Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 OPKO Health Main Business Overview
11.9.5 OPKO Health Latest Developments
11.10 23andMe
11.10.1 23andMe Company Information
11.10.2 23andMe Genetic Screening for Carrier Diseases Product Offered
11.10.3 23andMe Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 23andMe Main Business Overview
11.10.5 23andMe Latest Developments
11.11 bioMerieux
11.11.1 bioMerieux Company Information
11.11.2 bioMerieux Genetic Screening for Carrier Diseases Product Offered
11.11.3 bioMerieux Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 bioMerieux Main Business Overview
11.11.5 bioMerieux Latest Developments
11.12 EKF Diagnostics
11.12.1 EKF Diagnostics Company Information
11.12.2 EKF Diagnostics Genetic Screening for Carrier Diseases Product Offered
11.12.3 EKF Diagnostics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 EKF Diagnostics Main Business Overview
11.12.5 EKF Diagnostics Latest Developments
11.13 Gene by Gene (myDNA)
11.13.1 Gene by Gene (myDNA) Company Information
11.13.2 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product Offered
11.13.3 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Gene by Gene (myDNA) Main Business Overview
11.13.5 Gene by Gene (myDNA) Latest Developments
11.14 Fulgent Genetics
11.14.1 Fulgent Genetics Company Information
11.14.2 Fulgent Genetics Genetic Screening for Carrier Diseases Product Offered
11.14.3 Fulgent Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Fulgent Genetics Main Business Overview
11.14.5 Fulgent Genetics Latest Developments
11.15 NxGen MDx
11.15.1 NxGen MDx Company Information
11.15.2 NxGen MDx Genetic Screening for Carrier Diseases Product Offered
11.15.3 NxGen MDx Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 NxGen MDx Main Business Overview
11.15.5 NxGen MDx Latest Developments
11.16 Sonic Genetics
11.16.1 Sonic Genetics Company Information
11.16.2 Sonic Genetics Genetic Screening for Carrier Diseases Product Offered
11.16.3 Sonic Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Sonic Genetics Main Business Overview
11.16.5 Sonic Genetics Latest Developments
11.17 My Baby
11.17.1 My Baby Company Information
11.17.2 My Baby Genetic Screening for Carrier Diseases Product Offered
11.17.3 My Baby Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 My Baby Main Business Overview
11.17.5 My Baby Latest Developments
11.18 AncestryDNA
11.18.1 AncestryDNA Company Information
11.18.2 AncestryDNA Genetic Screening for Carrier Diseases Product Offered
11.18.3 AncestryDNA Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 AncestryDNA Main Business Overview
11.18.5 AncestryDNA Latest Developments
11.19 DiaSorin
11.19.1 DiaSorin Company Information
11.19.2 DiaSorin Genetic Screening for Carrier Diseases Product Offered
11.19.3 DiaSorin Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 DiaSorin Main Business Overview
11.19.5 DiaSorin Latest Developments
11.20 Grifols
11.20.1 Grifols Company Information
11.20.2 Grifols Genetic Screening for Carrier Diseases Product Offered
11.20.3 Grifols Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Grifols Main Business Overview
11.20.5 Grifols Latest Developments
11.21 BGI Genomics
11.21.1 BGI Genomics Company Information
11.21.2 BGI Genomics Genetic Screening for Carrier Diseases Product Offered
11.21.3 BGI Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 BGI Genomics Main Business Overview
11.21.5 BGI Genomics Latest Developments
11.22 Chigene
11.22.1 Chigene Company Information
11.22.2 Chigene Genetic Screening for Carrier Diseases Product Offered
11.22.3 Chigene Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Chigene Main Business Overview
11.22.5 Chigene Latest Developments
11.23 Jiajian Medical Testing
11.23.1 Jiajian Medical Testing Company Information
11.23.2 Jiajian Medical Testing Genetic Screening for Carrier Diseases Product Offered
11.23.3 Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Jiajian Medical Testing Main Business Overview
11.23.5 Jiajian Medical Testing Latest Developments
11.24 Genesky
11.24.1 Genesky Company Information
11.24.2 Genesky Genetic Screening for Carrier Diseases Product Offered
11.24.3 Genesky Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Genesky Main Business Overview
11.24.5 Genesky Latest Developments
11.25 Berry Genomics
11.25.1 Berry Genomics Company Information
11.25.2 Berry Genomics Genetic Screening for Carrier Diseases Product Offered
11.25.3 Berry Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Berry Genomics Main Business Overview
11.25.5 Berry Genomics Latest Developments
11.26 Weihansi Biomedical Technology
11.26.1 Weihansi Biomedical Technology Company Information
11.26.2 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product Offered
11.26.3 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Weihansi Biomedical Technology Main Business Overview
11.26.5 Weihansi Biomedical Technology Latest Developments
11.27 Annaroad
11.27.1 Annaroad Company Information
11.27.2 Annaroad Genetic Screening for Carrier Diseases Product Offered
11.27.3 Annaroad Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 Annaroad Main Business Overview
11.27.5 Annaroad Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Genetic Screening for Carrier Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Genetic Screening for Carrier Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of NGS
Table 4. Major Players of Whole Exome Sequencing
Table 5. Major Players of Others
Table 6. Genetic Screening for Carrier Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
Table 9. Genetic Screening for Carrier Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
Table 12. Global Genetic Screening for Carrier Diseases Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Genetic Screening for Carrier Diseases Revenue Market Share by Player (2021-2026)
Table 14. Genetic Screening for Carrier Diseases Key Players Head office and Products Offered
Table 15. Genetic Screening for Carrier Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Genetic Screening for Carrier Diseases Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Genetic Screening for Carrier Diseases Market Size Market Share by Region (2021-2026)
Table 20. Global Genetic Screening for Carrier Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Genetic Screening for Carrier Diseases Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Genetic Screening for Carrier Diseases Market Size Market Share by Country (2021-2026)
Table 24. Americas Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
Table 26. Americas Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
Table 28. APAC Genetic Screening for Carrier Diseases Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Genetic Screening for Carrier Diseases Market Size Market Share by Region (2021-2026)
Table 30. APAC Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Genetic Screening for Carrier Diseases Market Size Market Share by Country (2021-2026)
Table 34. Europe Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Genetic Screening for Carrier Diseases
Table 40. Key Market Challenges & Risks of Genetic Screening for Carrier Diseases
Table 41. Key Industry Trends of Genetic Screening for Carrier Diseases
Table 42. Global Genetic Screening for Carrier Diseases Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Genetic Screening for Carrier Diseases Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Genetic Screening for Carrier Diseases Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Genetic Screening for Carrier Diseases Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Thermo Fisher Scientific Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 47. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product Offered
Table 48. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Thermo Fisher Scientific Main Business
Table 50. Thermo Fisher Scientific Latest Developments
Table 51. Eurofins Scientific Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 52. Eurofins Scientific Genetic Screening for Carrier Diseases Product Offered
Table 53. Eurofins Scientific Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Eurofins Scientific Main Business
Table 55. Eurofins Scientific Latest Developments
Table 56. Illumina Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 57. Illumina Genetic Screening for Carrier Diseases Product Offered
Table 58. Illumina Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Illumina Main Business
Table 60. Illumina Latest Developments
Table 61. Invitae Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 62. Invitae Genetic Screening for Carrier Diseases Product Offered
Table 63. Invitae Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Invitae Main Business
Table 65. Invitae Latest Developments
Table 66. MedGenome Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 67. MedGenome Genetic Screening for Carrier Diseases Product Offered
Table 68. MedGenome Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. MedGenome Main Business
Table 70. MedGenome Latest Developments
Table 71. Myriad Genetics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 72. Myriad Genetics Genetic Screening for Carrier Diseases Product Offered
Table 73. Myriad Genetics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Myriad Genetics Main Business
Table 75. Myriad Genetics Latest Developments
Table 76. Roche Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 77. Roche Genetic Screening for Carrier Diseases Product Offered
Table 78. Roche Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Roche Main Business
Table 80. Roche Latest Developments
Table 81. Natera Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 82. Natera Genetic Screening for Carrier Diseases Product Offered
Table 83. Natera Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Natera Main Business
Table 85. Natera Latest Developments
Table 86. OPKO Health Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 87. OPKO Health Genetic Screening for Carrier Diseases Product Offered
Table 88. OPKO Health Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. OPKO Health Main Business
Table 90. OPKO Health Latest Developments
Table 91. 23andMe Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 92. 23andMe Genetic Screening for Carrier Diseases Product Offered
Table 93. 23andMe Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. 23andMe Main Business
Table 95. 23andMe Latest Developments
Table 96. bioM?rieux Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 97. bioM?rieux Genetic Screening for Carrier Diseases Product Offered
Table 98. bioM?rieux Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. bioM?rieux Main Business
Table 100. bioM?rieux Latest Developments
Table 101. EKF Diagnostics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 102. EKF Diagnostics Genetic Screening for Carrier Diseases Product Offered
Table 103. EKF Diagnostics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. EKF Diagnostics Main Business
Table 105. EKF Diagnostics Latest Developments
Table 106. Gene by Gene (myDNA) Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 107. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product Offered
Table 108. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Gene by Gene (myDNA) Main Business
Table 110. Gene by Gene (myDNA) Latest Developments
Table 111. Fulgent Genetics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 112. Fulgent Genetics Genetic Screening for Carrier Diseases Product Offered
Table 113. Fulgent Genetics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Fulgent Genetics Main Business
Table 115. Fulgent Genetics Latest Developments
Table 116. NxGen MDx Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 117. NxGen MDx Genetic Screening for Carrier Diseases Product Offered
Table 118. NxGen MDx Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. NxGen MDx Main Business
Table 120. NxGen MDx Latest Developments
Table 121. Sonic Genetics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 122. Sonic Genetics Genetic Screening for Carrier Diseases Product Offered
Table 123. Sonic Genetics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Sonic Genetics Main Business
Table 125. Sonic Genetics Latest Developments
Table 126. My Baby Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 127. My Baby Genetic Screening for Carrier Diseases Product Offered
Table 128. My Baby Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. My Baby Main Business
Table 130. My Baby Latest Developments
Table 131. AncestryDNA Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 132. AncestryDNA Genetic Screening for Carrier Diseases Product Offered
Table 133. AncestryDNA Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. AncestryDNA Main Business
Table 135. AncestryDNA Latest Developments
Table 136. DiaSorin Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 137. DiaSorin Genetic Screening for Carrier Diseases Product Offered
Table 138. DiaSorin Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. DiaSorin Main Business
Table 140. DiaSorin Latest Developments
Table 141. Grifols Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 142. Grifols Genetic Screening for Carrier Diseases Product Offered
Table 143. Grifols Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Grifols Main Business
Table 145. Grifols Latest Developments
Table 146. BGI Genomics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 147. BGI Genomics Genetic Screening for Carrier Diseases Product Offered
Table 148. BGI Genomics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. BGI Genomics Main Business
Table 150. BGI Genomics Latest Developments
Table 151. Chigene Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 152. Chigene Genetic Screening for Carrier Diseases Product Offered
Table 153. Chigene Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. Chigene Main Business
Table 155. Chigene Latest Developments
Table 156. Jiajian Medical Testing Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 157. Jiajian Medical Testing Genetic Screening for Carrier Diseases Product Offered
Table 158. Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Jiajian Medical Testing Main Business
Table 160. Jiajian Medical Testing Latest Developments
Table 161. Genesky Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 162. Genesky Genetic Screening for Carrier Diseases Product Offered
Table 163. Genesky Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 164. Genesky Main Business
Table 165. Genesky Latest Developments
Table 166. Berry Genomics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 167. Berry Genomics Genetic Screening for Carrier Diseases Product Offered
Table 168. Berry Genomics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 169. Berry Genomics Main Business
Table 170. Berry Genomics Latest Developments
Table 171. Weihansi Biomedical Technology Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 172. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product Offered
Table 173. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 174. Weihansi Biomedical Technology Main Business
Table 175. Weihansi Biomedical Technology Latest Developments
Table 176. Annaroad Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 177. Annaroad Genetic Screening for Carrier Diseases Product Offered
Table 178. Annaroad Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 179. Annaroad Main Business
Table 180. Annaroad Latest Developments
Table 1. Genetic Screening for Carrier Diseases Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Genetic Screening for Carrier Diseases Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of NGS
Table 4. Major Players of Whole Exome Sequencing
Table 5. Major Players of Others
Table 6. Genetic Screening for Carrier Diseases Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
Table 9. Genetic Screening for Carrier Diseases Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
Table 12. Global Genetic Screening for Carrier Diseases Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Genetic Screening for Carrier Diseases Revenue Market Share by Player (2021-2026)
Table 14. Genetic Screening for Carrier Diseases Key Players Head office and Products Offered
Table 15. Genetic Screening for Carrier Diseases Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Genetic Screening for Carrier Diseases Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Genetic Screening for Carrier Diseases Market Size Market Share by Region (2021-2026)
Table 20. Global Genetic Screening for Carrier Diseases Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Genetic Screening for Carrier Diseases Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Genetic Screening for Carrier Diseases Market Size Market Share by Country (2021-2026)
Table 24. Americas Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
Table 26. Americas Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
Table 28. APAC Genetic Screening for Carrier Diseases Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Genetic Screening for Carrier Diseases Market Size Market Share by Region (2021-2026)
Table 30. APAC Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Genetic Screening for Carrier Diseases Market Size Market Share by Country (2021-2026)
Table 34. Europe Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Genetic Screening for Carrier Diseases
Table 40. Key Market Challenges & Risks of Genetic Screening for Carrier Diseases
Table 41. Key Industry Trends of Genetic Screening for Carrier Diseases
Table 42. Global Genetic Screening for Carrier Diseases Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Genetic Screening for Carrier Diseases Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Genetic Screening for Carrier Diseases Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Genetic Screening for Carrier Diseases Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Thermo Fisher Scientific Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 47. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product Offered
Table 48. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Thermo Fisher Scientific Main Business
Table 50. Thermo Fisher Scientific Latest Developments
Table 51. Eurofins Scientific Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 52. Eurofins Scientific Genetic Screening for Carrier Diseases Product Offered
Table 53. Eurofins Scientific Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Eurofins Scientific Main Business
Table 55. Eurofins Scientific Latest Developments
Table 56. Illumina Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 57. Illumina Genetic Screening for Carrier Diseases Product Offered
Table 58. Illumina Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Illumina Main Business
Table 60. Illumina Latest Developments
Table 61. Invitae Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 62. Invitae Genetic Screening for Carrier Diseases Product Offered
Table 63. Invitae Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Invitae Main Business
Table 65. Invitae Latest Developments
Table 66. MedGenome Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 67. MedGenome Genetic Screening for Carrier Diseases Product Offered
Table 68. MedGenome Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. MedGenome Main Business
Table 70. MedGenome Latest Developments
Table 71. Myriad Genetics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 72. Myriad Genetics Genetic Screening for Carrier Diseases Product Offered
Table 73. Myriad Genetics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Myriad Genetics Main Business
Table 75. Myriad Genetics Latest Developments
Table 76. Roche Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 77. Roche Genetic Screening for Carrier Diseases Product Offered
Table 78. Roche Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Roche Main Business
Table 80. Roche Latest Developments
Table 81. Natera Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 82. Natera Genetic Screening for Carrier Diseases Product Offered
Table 83. Natera Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Natera Main Business
Table 85. Natera Latest Developments
Table 86. OPKO Health Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 87. OPKO Health Genetic Screening for Carrier Diseases Product Offered
Table 88. OPKO Health Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. OPKO Health Main Business
Table 90. OPKO Health Latest Developments
Table 91. 23andMe Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 92. 23andMe Genetic Screening for Carrier Diseases Product Offered
Table 93. 23andMe Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. 23andMe Main Business
Table 95. 23andMe Latest Developments
Table 96. bioM?rieux Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 97. bioM?rieux Genetic Screening for Carrier Diseases Product Offered
Table 98. bioM?rieux Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. bioM?rieux Main Business
Table 100. bioM?rieux Latest Developments
Table 101. EKF Diagnostics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 102. EKF Diagnostics Genetic Screening for Carrier Diseases Product Offered
Table 103. EKF Diagnostics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. EKF Diagnostics Main Business
Table 105. EKF Diagnostics Latest Developments
Table 106. Gene by Gene (myDNA) Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 107. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product Offered
Table 108. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Gene by Gene (myDNA) Main Business
Table 110. Gene by Gene (myDNA) Latest Developments
Table 111. Fulgent Genetics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 112. Fulgent Genetics Genetic Screening for Carrier Diseases Product Offered
Table 113. Fulgent Genetics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Fulgent Genetics Main Business
Table 115. Fulgent Genetics Latest Developments
Table 116. NxGen MDx Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 117. NxGen MDx Genetic Screening for Carrier Diseases Product Offered
Table 118. NxGen MDx Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. NxGen MDx Main Business
Table 120. NxGen MDx Latest Developments
Table 121. Sonic Genetics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 122. Sonic Genetics Genetic Screening for Carrier Diseases Product Offered
Table 123. Sonic Genetics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Sonic Genetics Main Business
Table 125. Sonic Genetics Latest Developments
Table 126. My Baby Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 127. My Baby Genetic Screening for Carrier Diseases Product Offered
Table 128. My Baby Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. My Baby Main Business
Table 130. My Baby Latest Developments
Table 131. AncestryDNA Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 132. AncestryDNA Genetic Screening for Carrier Diseases Product Offered
Table 133. AncestryDNA Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. AncestryDNA Main Business
Table 135. AncestryDNA Latest Developments
Table 136. DiaSorin Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 137. DiaSorin Genetic Screening for Carrier Diseases Product Offered
Table 138. DiaSorin Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. DiaSorin Main Business
Table 140. DiaSorin Latest Developments
Table 141. Grifols Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 142. Grifols Genetic Screening for Carrier Diseases Product Offered
Table 143. Grifols Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Grifols Main Business
Table 145. Grifols Latest Developments
Table 146. BGI Genomics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 147. BGI Genomics Genetic Screening for Carrier Diseases Product Offered
Table 148. BGI Genomics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. BGI Genomics Main Business
Table 150. BGI Genomics Latest Developments
Table 151. Chigene Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 152. Chigene Genetic Screening for Carrier Diseases Product Offered
Table 153. Chigene Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. Chigene Main Business
Table 155. Chigene Latest Developments
Table 156. Jiajian Medical Testing Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 157. Jiajian Medical Testing Genetic Screening for Carrier Diseases Product Offered
Table 158. Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Jiajian Medical Testing Main Business
Table 160. Jiajian Medical Testing Latest Developments
Table 161. Genesky Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 162. Genesky Genetic Screening for Carrier Diseases Product Offered
Table 163. Genesky Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 164. Genesky Main Business
Table 165. Genesky Latest Developments
Table 166. Berry Genomics Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 167. Berry Genomics Genetic Screening for Carrier Diseases Product Offered
Table 168. Berry Genomics Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 169. Berry Genomics Main Business
Table 170. Berry Genomics Latest Developments
Table 171. Weihansi Biomedical Technology Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 172. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product Offered
Table 173. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 174. Weihansi Biomedical Technology Main Business
Table 175. Weihansi Biomedical Technology Latest Developments
Table 176. Annaroad Details, Company Type, Genetic Screening for Carrier Diseases Area Served and Its Competitors
Table 177. Annaroad Genetic Screening for Carrier Diseases Product Offered
Table 178. Annaroad Genetic Screening for Carrier Diseases Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 179. Annaroad Main Business
Table 180. Annaroad Latest Developments
LIST OF FIGURES
Figure 1. Genetic Screening for Carrier Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Genetic Screening for Carrier Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Genetic Screening for Carrier Diseases Sales Market Share by Country/Region (2025)
Figure 8. Genetic Screening for Carrier Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Genetic Screening for Carrier Diseases Market Size Market Share by Type in 2025
Figure 10. Genetic Screening for Carrier Diseases in Couple
Figure 11. Global Genetic Screening for Carrier Diseases Market: Couple (2021-2026) & ($ millions)
Figure 12. Genetic Screening for Carrier Diseases in Individual
Figure 13. Global Genetic Screening for Carrier Diseases Market: Individual (2021-2026) & ($ millions)
Figure 14. Global Genetic Screening for Carrier Diseases Market Size Market Share by Application in 2025
Figure 15. Global Genetic Screening for Carrier Diseases Revenue Market Share by Player in 2025
Figure 16. Global Genetic Screening for Carrier Diseases Market Size Market Share by Region (2021-2026)
Figure 17. Americas Genetic Screening for Carrier Diseases Market Size 2021-2026 ($ millions)
Figure 18. APAC Genetic Screening for Carrier Diseases Market Size 2021-2026 ($ millions)
Figure 19. Europe Genetic Screening for Carrier Diseases Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Genetic Screening for Carrier Diseases Market Size 2021-2026 ($ millions)
Figure 21. Americas Genetic Screening for Carrier Diseases Value Market Share by Country in 2025
Figure 22. United States Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Genetic Screening for Carrier Diseases Market Size Market Share by Region in 2025
Figure 27. APAC Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
Figure 28. APAC Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
Figure 29. China Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 33. India Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Genetic Screening for Carrier Diseases Market Size Market Share by Country in 2025
Figure 36. Europe Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
Figure 37. Europe Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
Figure 38. Germany Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 39. France Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Genetic Screening for Carrier Diseases Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 52. APAC Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 53. Europe Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 55. United States Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 56. Canada Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 57. Mexico Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 58. Brazil Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 59. China Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 60. Japan Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 61. Korea Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 63. India Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 64. Australia Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 65. Germany Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 66. France Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 67. UK Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 68. Italy Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 69. Russia Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 70. Egypt Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 71. South Africa Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 72. Israel Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 73. Turkey Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 74. Global Genetic Screening for Carrier Diseases Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Genetic Screening for Carrier Diseases Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 1. Genetic Screening for Carrier Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Genetic Screening for Carrier Diseases Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Genetic Screening for Carrier Diseases Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Genetic Screening for Carrier Diseases Sales Market Share by Country/Region (2025)
Figure 8. Genetic Screening for Carrier Diseases Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Genetic Screening for Carrier Diseases Market Size Market Share by Type in 2025
Figure 10. Genetic Screening for Carrier Diseases in Couple
Figure 11. Global Genetic Screening for Carrier Diseases Market: Couple (2021-2026) & ($ millions)
Figure 12. Genetic Screening for Carrier Diseases in Individual
Figure 13. Global Genetic Screening for Carrier Diseases Market: Individual (2021-2026) & ($ millions)
Figure 14. Global Genetic Screening for Carrier Diseases Market Size Market Share by Application in 2025
Figure 15. Global Genetic Screening for Carrier Diseases Revenue Market Share by Player in 2025
Figure 16. Global Genetic Screening for Carrier Diseases Market Size Market Share by Region (2021-2026)
Figure 17. Americas Genetic Screening for Carrier Diseases Market Size 2021-2026 ($ millions)
Figure 18. APAC Genetic Screening for Carrier Diseases Market Size 2021-2026 ($ millions)
Figure 19. Europe Genetic Screening for Carrier Diseases Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Genetic Screening for Carrier Diseases Market Size 2021-2026 ($ millions)
Figure 21. Americas Genetic Screening for Carrier Diseases Value Market Share by Country in 2025
Figure 22. United States Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Genetic Screening for Carrier Diseases Market Size Market Share by Region in 2025
Figure 27. APAC Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
Figure 28. APAC Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
Figure 29. China Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 33. India Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Genetic Screening for Carrier Diseases Market Size Market Share by Country in 2025
Figure 36. Europe Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
Figure 37. Europe Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
Figure 38. Germany Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 39. France Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Genetic Screening for Carrier Diseases Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Genetic Screening for Carrier Diseases Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Genetic Screening for Carrier Diseases Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Genetic Screening for Carrier Diseases Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 52. APAC Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 53. Europe Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 55. United States Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 56. Canada Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 57. Mexico Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 58. Brazil Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 59. China Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 60. Japan Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 61. Korea Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 63. India Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 64. Australia Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 65. Germany Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 66. France Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 67. UK Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 68. Italy Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 69. Russia Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 70. Egypt Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 71. South Africa Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 72. Israel Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 73. Turkey Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
Figure 74. Global Genetic Screening for Carrier Diseases Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Genetic Screening for Carrier Diseases Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Genetic Screening for Carrier Diseases Market Size 2027-2032 ($ millions)
